{"public_id":"co_284983ab4519b63fa15bbf5fd0cc8ee5","status":"active","merged_into_public_id":null,"resolved_public_id":"co_284983ab4519b63fa15bbf5fd0cc8ee5","name":"viremic patients","description":"HCV-infected patients with detectable viral RNA in serum.","aliases":["HCV patients with viremia"],"types":["patient group"],"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"concept","status":"active","confidence":null,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","concept.status"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"papers":[{"corpus_id":5688445,"title":"Circulating viral core and E1 antigen levels as supplemental markers for HCV Chronic hepatitis","citation_count":16,"url":"https://sah.borca.ai/papers/5688445"}],"claims":[{"public_id":"cl_a1d64ef8e5f14de55923ae736bf7b2b1","text":"Core and E1 antigen levels are significantly higher in viremic HCV patients than in controls.","corpus_id":5688445,"url":"https://sah.borca.ai/claims/cl_a1d64ef8e5f14de55923ae736bf7b2b1"}],"related_concepts":[],"resolved_url":"https://sah.borca.ai/concepts/co_284983ab4519b63fa15bbf5fd0cc8ee5","url":"https://sah.borca.ai/concepts/co_284983ab4519b63fa15bbf5fd0cc8ee5"}